Literature DB >> 7510883

Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.

J R Vane1, J A Mitchell, I Appleton, A Tomlinson, D Bishop-Bailey, J Croxtall, D A Willoughby.   

Abstract

Cyclooxygenase (COX) converts arachidonic acid to prostaglandin H2, which is further metabolized to prostanoids. Two isoforms of COX exist: a constitutive (COX-1) and an inducible (COX-2) enzyme. Nitric oxide is derived from L-arginine by isoforms of nitric-oxide synthase (NOS; EC 1.14.13.39): constitutive (cNOS; calcium-dependent) and inducible (iNOS; calcium-independent). Here we have investigated inducible isoforms of COX and NOS in the acute, chronic, and resolving stages of a murine air pouch model of granulomatous inflammation. COX and NOS activities were measured in skin samples in the acute phase, up to 24 h. Activities in granulomatous tissue were measured at 3, 5, 7, 14, and 21 days for the chronic and resolving stages of inflammation. COX-1 and COX-2 proteins were assessed by Western blot. COX activity in the skin increased over the first 24 h and continued to rise up to day 14. COX-2 protein rose progressively, also peaking at day 14. COX-1 protein remained unaltered throughout. The iNOS activity increased over the first 24 h in the skin, with a further major increase in the granulomatous tissue between days 3 and 7, followed by a decrease at day 14 and a further increase at day 21. The rise in COX and NOS activities in the skin during the acute phase reinforces the proinflammatory role for prostanoids and suggests one also for nitric oxide. However, in the chronic and resolving stages, a dissociation of COX and NOS activity occurred. Thus, there may be differential regulation of these enzymes, perhaps due to the changing pattern of cytokines during the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7510883      PMCID: PMC43306          DOI: 10.1073/pnas.91.6.2046

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Control of lymphokine secretion by prostaglandins.

Authors:  D Gordon; M A Bray; J Morley
Journal:  Nature       Date:  1976-07-29       Impact factor: 49.962

3.  Endothelium-dependent inhibition of platelet aggregation.

Authors:  H Azuma; M Ishikawa; S Sekizaki
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

4.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

5.  The VLA protein family. Characterization of five distinct cell surface heterodimers each with a common 130,000 molecular weight beta subunit.

Authors:  M E Hemler; C Huang; L Schwarz
Journal:  J Biol Chem       Date:  1987-03-05       Impact factor: 5.157

6.  Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Lancet       Date:  1987-11-07       Impact factor: 79.321

Review 7.  Inflammation and the mechanism of action of anti-inflammatory drugs.

Authors:  J Vane; R Botting
Journal:  FASEB J       Date:  1987-08       Impact factor: 5.191

8.  Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1.

Authors:  C R Albrightson; N L Baenziger; P Needleman
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

9.  Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774.

Authors:  P Marotta; L Sautebin; M Di Rosa
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

10.  Restoration of prostacyclin synthase in vascular smooth muscle cells after aspirin treatment: regulation by epidermal growth factor.

Authors:  J M Bailey; B Muza; T Hla; K Salata
Journal:  J Lipid Res       Date:  1985-01       Impact factor: 5.922

View more
  185 in total

1.  A771726, the active metabolite of leflunomide, directly inhibits the activity of cyclo-oxygenase-2 in vitro and in vivo in a substrate-sensitive manner.

Authors:  L C Hamilton; I Vojnovic; T D Warner
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 2.  Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach.

Authors:  N M Davies; N M Skjodt
Journal:  Clin Pharmacokinet       Date:  2000-05       Impact factor: 6.447

3.  Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate.

Authors:  X M Xu; L Sansores-Garcia; X M Chen; N Matijevic-Aleksic; M Du; K K Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

4.  Preventing NSAID Toxicity to the Upper Gastrointestinal Tract.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-06

Review 5.  Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications.

Authors:  Daniela Salvemini; Sangwon F Kim; Vincenzo Mollace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-06       Impact factor: 3.619

Review 6.  Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.

Authors:  Roberto Bolli; Ken Shinmura; Xian-Liang Tang; Eitaro Kodani; Yu-Ting Xuan; Yiru Guo; Buddhadeb Dawn
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

7.  Coingestion of cyclooxygenase inhibitors can worsen severe paracetamol poisoning by middle-sized and small arteries vasoconstriction.

Authors:  Francis Schneider; Agnès Neuville; Ferhat Meziani; Carole Meyer; Parissa Assemi; Thierry Lavigne; Vincent Castelain
Journal:  Intensive Care Med       Date:  2003-09-26       Impact factor: 17.440

8.  Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.

Authors:  F Fabi; R Calabrese; T Stati; P del Basso
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

9.  Infiltration of inflammatory cells plays an important role in matrix metalloproteinase expression and activation in the heart during sepsis.

Authors:  Jimena Cuenca; Paloma Martín-Sanz; Alberto M Alvarez-Barrientos; Lisardo Boscá; Nora Goren
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

10.  The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase.

Authors:  A R Amin; P Vyas; M Attur; J Leszczynska-Piziak; I R Patel; G Weissmann; S B Abramson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.